SCM
EW icon

Stevens Capital Management’s Edwards Lifesciences EW Stock Holding History

Stevens Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,847
Closed -$413K – 251
2025
Q4 		$413K Buy
4,847
+441
+10% +$36.2K 0.15% 133
2025
Q3 		$343K Buy
+4,406
New +$344K 0.05% 192
2024
Q1 		– Sell
-15,090
Closed -$1.15M – 297
2023
Q4 		$1.15M Buy
15,090
+2,311
+18% +$161K 0.29% 77
2023
Q3 		$885K Buy
+12,779
New +$1.03M 0.26% 98
2020
Q1 		– Sell
-90,948
Closed -$7.07M – 140
2019
Q4 		$7.07M Buy
+90,948
New +$7.1M 0.66% 32
2019
Q3 		– Sell
-25,038
Closed -$1.54M – 618
2019
Q2 		$1.54M Buy
+25,038
New +$1.51M 0.07% 294
2017
Q4 		– Sell
-90,303
Closed -$3.29M – 884
2017
Q3 		$3.29M Buy
+90,303
New +$3.44M 0.12% 225
2017
Q2 		– Sell
-111,081
Closed -$3.48M – 903
2017
Q1 		$3.48M Buy
+111,081
New +$3.48M 0.13% 221
2016
Q3 		– Sell
-645,336
Closed -$21.5M – 964
2016
Q2 		$21.5M Buy
645,336
+633,975
+5,580% +$21.7M 0.86% 17
2016
Q1 		$334K Sell
11,361
-347,844
-97% -$9.6M 0.01% 662
2015
Q4 		$9.46M Buy
+359,205
New +$9.33M 0.37% 72
2015
Q1 		– Sell
-229,632
Closed -$4.88M – 1045
2014
Q4 		$4.88M Buy
+229,632
New +$4.61M 0.16% 161
2013
Q4 		– Sell
-303,114
Closed -$3.52M – 1065
2013
Q3 		$3.52M Buy
+303,114
New +$3.55M 0.1% 253

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Stevens Capital Management's EW Position: Q1 2026 in Review

Stevens Capital Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 4,847 shares — an estimated $413K sold.

Stevens Capital Management first reported a position in EW in Q3 2013 and held it in 13 quarters. The position peaked at $21.5M in Q2 2016. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Stevens Capital Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Stevens Capital Management sold 4,847 Edwards Lifesciences shares in Q1 2026, an estimated $413K.
  • Stevens Capital Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 13 quarters.
  • Stevens Capital Management's Edwards Lifesciences position peaked at $21.5M in Q2 2016.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Stevens Capital Management's 13F filing for Q1 2026, filed 11 May 2026.